From: Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
Clinical status | Genotypes HLA-DRB1*11/12 | ||||||
---|---|---|---|---|---|---|---|
+/+ | +/- | -/+ | -/- | p-value | OR | 95% CI | |
CC- (n = 48) | 2 (4.2) | 2 (4.2) | 1 (2.1) | 43 (89.6) | 0.651a | 1.971 | [0.312–12.444] |
CC+ (n = 38) | 3 (7.9) | 10 (26.3) | 5 (13.2) | 20 (52.6) | 0.725b | 1.533 | [0.307–7.665] |
SC+ (n = 52) | 6 (11.5) | 3 (5.8) | 3 (5.8) | 40 (76.9) | 0.728c | 1.522 | [0.356–6.513] |
NC+ (n = 60) | 1 (1.7) | 11 (18.3) | 8 (13.3) | 40 (66.7) | 0.296d | 0.198 | [0.020–1.975] |
Total (n = 198) | 12 (6.1) | 26 (13.1) | 17 (8.6) | 143 (72.2) | 0.048e | 7.695 | [0.895–66.189] |